1. Market Research
  2. > Pharmaceutical Market Trends
Drugs for Infertility: Global Markets to 2022

Drugs for Infertility: Global Markets to 2022

  • March 2018
  • 167 pages
  • ID: 5363517

Summary

Table of Contents

Scope of Report:
This research report categorizes the drugs for infertility market by type. Segments include Anti-Estrogens and Gonadotropins.

Report Includes:
- 95 data tables
- An overview of the global market for infertility drugs and their future demand
- Analyses of global market trends, with data from 2013 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of the various causes of infertility among men and women and pharmaceutical drugs that enhance the reproductive fertility
- Insight into the type of infertility drugs, i.e., anti-estrogens and gonadotropins
- Profiles of major companies in the market, including Bayer, Merck, Sanofi, Ferring Holding and Abbott Laboratories

Summary
The global drugs for infertility market is registering growth due to growing infertile population and rising awareness about infertility treatments in both developed and developing countries. At the same time, economic growth in emerging countries, increasing prevalence of obesity and new methods of drug development are also driving the drugs for infertility market.

The market for drugs for infertility reached a value of nearly REDACTED in 2017 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED to nearly REDACTED by 2022.

The market for drugs for infertility is concentrated with a few large players dominating the market.Major players in the market are Bayer, Merck, Sanofi, Ferring Holding, Abbott Laboratories and others.

Gonadotropins accounted for the largest share of the market for drugs for infertility in 2017 at REDACTED.The highest growth is projected to come from Gonadotropins, which is forecasted to grow at a CAGR of REDACTED.

Major factors included increasing demand for fertility treatments, especially in Asia-Pacific andSouth America, changing government regulations related to operation of chorionic gonadotropin and increasing investments on product differentiations.

North America is the largest market for drugs for infertility, accounting for REDACTED of the global market.It was followed by Asia-Pacific and Africa.

Going forward, Eastern Europe is expected to witness the fastest growth in the drugs for infertility market, estimated at grow at a CAGR of REDACTED, followed by South America, which is expected to grow at a CAGR of REDACTED.

The USA is the largest market in terms of value in the drugs for infertility market. Brazil and China are forecasted to have the fastest growth, growing at a CAGR of REDACTED and REDACTED, respectively.

The market is challenged by restraints such as patent expiry of fertility drugs, high costs of fertility treatments and pricing pressures from regulators.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 23500
  • Industry report
  • June 2018
  • by Venture Planning Group

The report is a seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...

2018 POC Diagnostic Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

2018 POC Diagnostic Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

  • $ 16600
  • Industry report
  • August 2018
  • by Venture Planning Group

This new report provides comprehensive analysis of the ten POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging ...

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

  • $ 15900
  • Industry report
  • June 2018
  • by Venture Planning Group

This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; ...


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on